As on February 10, 2021, Altimmune Inc. (NASDAQ: ALT) started slowly as it slid -2.36% to $21.07. During the day, the stock rose to $22.8365 and sunk to $19.20 before settling in for the price of $21.58 at the close. Taking a more long-term approach, ALT posted a 52-week range of $1.60-$35.10.
It was noted that the giant of the Healthcare sector posted annual sales growth of -10.70% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 50.20%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 89.50%. This publicly-traded company’s shares outstanding now amounts to $33.06 million, simultaneously with a float of $30.92 million. The organization now has a market capitalization sitting at $671.29 million. At the time of writing, stock’s 50-day Moving Average stood at $13.94, while the 200-day Moving Average is $13.67.
It is quite fundamental to gauge the extent of the productivity of the business which is accounted for 25 workers. It has generated 232,056 per worker during the last fiscal year. Meanwhile, its income per employee was -820,805. The stock had 1.90 Receivables turnover and 0.11 Total Asset turnover. For the Profitability, stocks operating margin was -293.63 and Pretax Margin of -354.72.
Altimmune Inc. (ALT) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Altimmune Inc.’s current insider ownership accounts for 1.20%, in contrast to 72.50% institutional ownership. According to the most recent insider trade that took place on Dec 10, this organization’s Director bought 2,000 shares at the rate of 11.99, making the entire transaction reach 23,980 in total value, affecting insider ownership by 8,900. Preceding that transaction, on Dec 01, Company’s Director sold 1,227 for 13.54, making the whole transaction’s value amount to 16,614. This particular insider is now the holder of 0 in total.
Altimmune Inc. (ALT) Earnings and Revenue Records
If we go through the results of last quarter, which was made public on 9/29/2020, the company posted -$0.54 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -$0.76) by $0.22. This company achieved a net margin of -353.71 while generating a return on equity of -43.74. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
Altimmune Inc.’s EPS increase for this current 12-month fiscal period is 89.50% and is forecasted to reach -1.06 in the upcoming year.
Altimmune Inc. (NASDAQ: ALT) Trading Performance Indicators
Let’s observe the current performance indicators for Altimmune Inc. (ALT). It’s Quick Ratio in the last reported quarter now stands at 34.70. The Stock has managed to achieve an average true range (ATR) of 1.83. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 104.89.
In the same vein, ALT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.00, a figure that is expected to reach -0.79 in the next quarter, and analysts are predicting that it will be -1.06 at the market close of one year from today.
Technical Analysis of Altimmune Inc. (ALT)
Through scrutinizing the latest numbers posted by the [Altimmune Inc., ALT], it can be observed that its last 5-days Average volume of 1.9 million was better the volume of 1.83 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 84.69% While, its Average True Range was 2.07.
Raw Stochastic average of Altimmune Inc. (ALT) in the period of the previous 100 days is set at 88.25%, which indicates a major rise in contrast to 82.36% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 132.94% that was higher than 129.62% volatility it exhibited in the past 100-days period.